Paige Obtains NHSx Award Allowing It To Launch AI Prostate Test

NHSx has awarded Paige an undisclosed sum of money to support development of its AI-powered prostate cancer detection tool in clinical settings in the UK.

Prostate tissue stained with hematoxylin & eosin • Source: Alamy

Paige, a company spun out of Memorial Sloan Kettering cancer center in New York, is developing advanced artificial intelligence (AI) systems for diagnosing prostate cancer and has been awarded an undisclosed sum of money as part of the NHSx Artificial Intelligence Health and Care Award.

NHSx is a unit of the UK government tasked with technologically modernizing the country’s National Health Service (NHS), while also setting national polity for the best practice of NHS...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from AI

More from Digital Technologies